SecBot SecBot
8-K ·Filed Oct 2, 2026

CHRN

ChronoScale Holdings Corp
BULLISH
Impact 6/10
Horizonmonths Processed24d ago SEC0001493152-26-045612
8-K context-dependent: Items 5.02, 7.01
Actionable Insight ▲ Bullish

The $1B run-rate target is ambitious and contingent on timely deployment, power availability, and capital access. Monitor future 10-Qs for progress on infrastructure deployment and customer revenue recognition. The recent DEFA14A proxy filing suggests board-level dynamics that could affect execution.

DirectionBullish
Confidencehigh
Horizonmonths
Latest settled — T+5d
CHRN ▼ -3.87% at T+5d
LONG call ✗ call lost -3.87% · α vs SPY -4.29% · entry $18.60 → $17.88
Next anchor: T+20d in 4d
Latest observation: T+14 -6.44% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
+3.66%
call +3.66% · α +3.11%
$19.28
settled 21d ago
T+5d
-3.87%
call -3.87% · α -4.29%
$17.88
settled 17d ago
T+20d
Pending
in 4d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

ChronoScale completed the sale of its Ekso Bionics unit and announced two new AI infrastructure customer agreements that, combined with existing contracts, are expected to drive annualized run-rate revenue to $1 billion by Q3 2027. The company also terminated the designation of its Series B Convertible Preferred Stock (no shares outstanding) and entered into a severance agreement with the former COO of Ekso for $243,750. The divestiture sharpens focus on the core AI compute business, while the revenue target is a forward-looking non-GAAP metric subject to execution risk.

Key Facts

  • ChronoScale completed the sale of its Ekso Bionics business unit, allowing it to focus on AI infrastructure.
  • Signed a contract extension with an existing AI infrastructure customer and a new customer agreement.
  • Together with existing contracts, the company expects annualized run-rate revenue of $1 billion by calendar Q3 2027.
  • The $1 billion run-rate is a non-GAAP metric calculated by multiplying quarterly recognized revenue by four, not a forecast.
  • Jason C. Jones, former COO of Ekso, was terminated in connection with the sale and will receive a $243,750 lump-sum severance plus COBRA coverage for up to nine months.
  • The company filed a Withdrawal of Designation for its Series B Convertible Preferred Stock; no shares were outstanding.
  • A DEFA14A proxy solicitation was filed 7 days prior, indicating recent contested election or board-related activity.

Financial Impact

Contracted annualized run-rate revenue target of $1 billion by Q3 2027; severance payment of $243,750; sale of Ekso Bionics (undisclosed value).

revenuerun-rate revenuecash

Risk Factors

  • Achievement of $1B run-rate depends on successful deployment, power/equipment availability, and access to capital on acceptable terms.
  • Customer concentration risk — the expansion involves an existing customer, and renewal/expansion is not guaranteed.
  • Forward-looking revenue metric is non-GAAP and not a forecast; actual revenue may differ materially.
  • The company may need to raise additional capital to fund GPU and infrastructure capex, which could be dilutive.

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-045612
Exhibit: ex99-1.htm0001493152-26-045612
Document: 0001493152-26-045612-index-headers.html0001493152-26-045612
Document: 0001493152-26-045612-index.html0001493152-26-045612
Document: 0001493152-26-045612.txt0001493152-26-045612
17 reports for CHRN
Performance horizon
67% Hit rate @ T+1 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+1▲ +8.77%Oct 13, 2026
Filters
Rows
Reports for CHRN — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
DEFA14A
NEUTRAL ★ 3/10
$14.97 $15.76▲ +5.28%▲ +4.94%$14.63 (−2.27%)
Oct 15, 2026
11d ago
8-K
MIXED ★ 6/10
$15.08 $14.97▼ −0.73%▼ −1.15%$14.63 (−2.98%)
Oct 15, 2026
11d ago
Press Release
MIXED ★ 6/10
$15.08 $14.97▼ −0.73%▼ −1.15%$14.63 (−2.98%)
Oct 13, 2026
13d ago
EFFECT
BEARISH ★ 5/10
$16.31 $14.88▲ +8.77%▲ +7.69%$14.63 (+10.30%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$19.77 $19.03▼ −3.74%▼ −3.32%$14.63 (−26.00%)
Oct 6, 2026
20d ago
S-3
NEUTRAL ★ 3/10
$19.77 $19.03▼ −3.74%▼ −3.32%$14.63 (−26.00%)
Oct 2, 2026
24d ago
8-K
BULLISH ★ 6/10
$18.60 $19.28▲ +3.66%▲ +3.11%$14.63 (−21.34%)
Oct 1, 2026
24d ago
Press Release
BULLISH ★ 6/10
$19.21 $18.60▼ −3.18%▼ −3.85%$14.63 (−23.84%)
Sep 25, 2026
4w ago
DEFA14A
NEUTRAL ★ 5/10
$19.82 $19.75▼ −0.33%▼ −0.14%$14.63 (−26.17%)
Sep 25, 2026
4w ago
DEF 14A
NEUTRAL ★ 4/10
$19.82 $19.75▼ −0.33%▼ −0.14%$14.63 (−26.17%)
Showing 10 of 17

US Market Status

Market Closed — Opens Tue (16h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026